U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
EPRATUZUMAB
INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
EPRATUZUMAB [MART.]
Common Name English
EPRATUZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
LYMPHOCIDE
Brand Name English
IMMU-HLL2
Code English
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
HLL2
Code English
IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
AMG-412
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
EPRATUZUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
Epratuzumab [WHO-DD]
Common Name English
epratuzumab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 260908
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
FDA ORPHAN DRUG 113298
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
Code System Code Type Description
EVMPD
SUB31567
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
NCI_THESAURUS
C1887
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108404
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
DRUG BANK
DB04958
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
USAN
KK-47
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
WIKIPEDIA
Epratuzumab
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
INN
7920
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
CAS
205923-57-5
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
MERCK INDEX
m4957
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY Merck Index
FDA UNII
3062P60MH9
Created by admin on Sat Dec 16 14:55:17 GMT 2023 , Edited by admin on Sat Dec 16 14:55:17 GMT 2023
PRIMARY
ACTIVE MOIETY
EPRATUZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966